Zobrazeno 1 - 10
of 3 450
pro vyhledávání: '"Chronic myeloid leukaemia"'
Autor:
Shweta Agarwal, Shruti Sharma, Monal Trisal, Zeeba S Jairajpuri, Sujala Kapur, Sumita Saluja, Purnima Paliwal
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 18, Iss 11, Pp 01-06 (2024)
Introduction: The bone marrow examination is an essential investigation in the diagnosis and management of many haematological disorders. The integration of all investigations, including peripheral blood analysis, bone marrow aspirate, and trephine b
Externí odkaz:
https://doaj.org/article/ab147597715043dfa8a1f5326789bd0f
Autor:
Elisha A. Nelson, Ibrahim O. Ahmed, Rahman A. Bolarinwa, Babatunde A. Adeagbo, Adebanjo J. Adegbola, Lateef Salawu, Oluseye O. Bolaji, Muheez A. Durosinmi
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-7 (2024)
Abstract Background In Nigeria, since 2002, Imatinib mesylate (glivec®) has been available freely to chronic myeloid leukaemia (CML) patients but only at a tertiary health care centre in the southwestern part of the country. Despite this, it is not
Externí odkaz:
https://doaj.org/article/230e939148a844e3a98b620494bda0b2
Autor:
Fiona Fernando, Maria Sol Andres, Simone Claudiani, Nazanin Zounemat Kermani, Giulia Ceccarelli, Andrew J. Innes, Afzal Khan, Stuart D. Rosen, Jane F. Apperley, Alexander R. Lyon, Dragana Milojkovic
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-10 (2024)
Abstract Background The therapeutic landscape of chronic myeloid leukaemia (CML) has been transformed by tyrosine kinase inhibitors (TKI). Nilotinib, showed higher rates of major molecular response than imatinib, however associated with higher cardio
Externí odkaz:
https://doaj.org/article/f3fb29a7cf9b43e2b4d17bd6d64a0418
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background The role of familial influence in chronic myeloid leukaemia (CML) occurrence is less defined. Previously, we conducted a study to determine the prevalence of harbouring BCR::ABL1 in our local adult normal population (designated as
Externí odkaz:
https://doaj.org/article/23e1317e0c2c4f7ba979aa1873e6a4ed
Autor:
Renren Zheng, Wei Wei, Suotian Liu, Dachuan Zeng, Zesong Yang, Jie Tang, Jinfeng Tan, Zhenglan Huang, Miao Gao
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background Abnormally expressed BCR/ABL protein serves as the basis for the development of chronic myeloid leukaemia (CML). The F-actin binding domain (FABD), which is a crucial region of the BCR/ABL fusion protein, is also located at the ca
Externí odkaz:
https://doaj.org/article/699d64ae3d1b4ce79f0523f833c618c7
Autor:
Olga S. Tatarinova, Caroline L. Furness, Andrew M. Borman, Joy Barber, Nagarajan Muthialu, Laura Ferreras-Antolin
Publikováno v:
Medical Mycology Case Reports, Vol 44, Iss , Pp 100645- (2024)
Neosartorya udagawae is a known cause of fungal infection in humans and animals. It is found to be more refractory to antifungal treatment in comparison to other Aspergillus species. With this report we present a case of proven invasive infection wit
Externí odkaz:
https://doaj.org/article/6d1a0fe7c38046d6980d1045f86c7112
Autor:
Katarzyna Gibek
Publikováno v:
Contemporary Oncology, Vol 27, Iss 4, Pp 277-283 (2024)
Externí odkaz:
https://doaj.org/article/54880a8ff1354a79b8559a3334ff7436
Autor:
Karg, Elena, Baldow, Christoph, Zerjatke, Thomas, Clark, Richard E., Roeder, Ingo, Fassoni, Artur C., Glauche, Ingmar
Introduction: Discontinuation of tyrosine kinase inhibitor (TKI) treatment is emerging as the main therapy goal for Chronic Myeloid Leukemia (CML) patients. The DESTINY trial showed that TKI dose reduction prior to cessation can lead to an increased
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A91771
https://tud.qucosa.de/api/qucosa%3A91771/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A91771/attachment/ATT-0/
Autor:
Sakditad Saowapa, Watsachon Pangkanon, Yaw Adu, Nattanicha Chaisrimaneepan, Diego Olavarria Bernal, Natchaya Polpichai, Pharit Siladech, Jasmine Sekhon
Publikováno v:
European Journal of Case Reports in Internal Medicine (2024)
Chronic lymphocytic leukaemia (CLL) is a lymphoproliferative disorder characterised by an accumulation of monoclonal B lymphocytes, with an increased risk of secondary cancers. The coexistence of CLL and chronic myeloid leukaemia (CML) is a rare phen
Externí odkaz:
https://doaj.org/article/c3c12c85ec4a4889a030b86912720ace
Publikováno v:
TNOA Journal of Ophthalmic Science and Research, Vol 62, Iss 1, Pp 94-96 (2024)
Chronic myeloid leukaemia (CML) in a patient with pre-existing uncontrolled diabetes and hypertension is rarely encountered but must be detected early for appropriate management with systemic chemotherapy. Significant fundus finding mimic diabetic an
Externí odkaz:
https://doaj.org/article/1b368a343ada4afa94f0aeafbcefb9bd